Express Scripts Says Customers Support Removal Of Several Pfizer Products From Formulary
This article was originally published in The Pink Sheet Daily
Executive Summary
Decision to drop Lipitor and Norvasc from its 2006 formulary represents an opportunity for savings without compromising health outcomes, the PBM says.
You may also be interested in...
Express Scripts Sees Rapid Switching to Zocor
The success at switching patients to Zocor ahead of the availability of a generic demonstrates the success of PBMs in driving market share, CEO Paz says.
Express Scripts Sees Rapid Switching to Zocor
The success at switching patients to Zocor ahead of the availability of a generic demonstrates the success of PBMs in driving market share, CEO Paz says.
FDA’s Trigger Policy For Generic Lawsuit Decisions “Facilitates Certainty,” Court Rules
The decision will uphold FDA’s newly created policy, barring a dissenting opinion from the District Court of Appeals.